Ixazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, a type of white blood cell cancer, in combination with other drugs. It is...
17 KB (1,693 words) - 06:49, 1 July 2024
ciclesonide. On November, the U.S. Food and Drug Administration approved Ixazomib developed by Takeda for use in combination with lenalidomide and dexamethasone...
33 KB (2,778 words) - 01:29, 7 September 2024
pomalidomide), and a proteasome inhibitor (e.g., or bortezomib, carfilzomib or ixazomib), in combination with a steroid (e.g., dexamethasone). While triplet therapies...
131 KB (13,506 words) - 01:17, 6 November 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
15 KB (1,090 words) - 15:26, 1 November 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
31 KB (2,908 words) - 06:38, 22 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
37 KB (3,396 words) - 23:51, 7 November 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
19 KB (1,757 words) - 09:15, 29 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
20 KB (1,915 words) - 00:12, 31 March 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
79 KB (9,506 words) - 22:52, 7 November 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
31 KB (2,832 words) - 13:30, 20 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
14 KB (1,105 words) - 06:03, 14 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
9 KB (716 words) - 15:15, 27 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
26 KB (2,420 words) - 15:49, 26 June 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
33 KB (2,959 words) - 02:09, 16 July 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
5 KB (324 words) - 12:07, 20 July 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
13 KB (869 words) - 05:58, 10 June 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
18 KB (1,467 words) - 23:44, 20 August 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
38 KB (3,966 words) - 00:02, 22 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
31 KB (2,796 words) - 07:50, 10 August 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
45 KB (4,765 words) - 15:32, 26 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
27 KB (2,575 words) - 15:22, 28 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
25 KB (2,190 words) - 23:26, 24 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
49 KB (4,454 words) - 18:07, 8 August 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
10 KB (592 words) - 08:12, 22 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
24 KB (2,260 words) - 18:03, 5 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
92 KB (12,517 words) - 05:38, 1 October 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
19 KB (1,553 words) - 19:42, 17 May 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
17 KB (1,321 words) - 00:56, 12 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
16 KB (1,041 words) - 22:27, 20 September 2024
Palbociclib Ribociclib Seliciclib†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib...
3 KB (98 words) - 05:18, 1 January 2024